Research that Identifies
Undiscovered Value in the MicroCap Market



SIMULATIONS PLUS, INC.

Simulations Plus Email List: Click to Subscribe

View Company Website: Click to View

Market Data: Yahoo Finance, Bloomberg, SEC Filings

Report Link: Updated Research Report (Dated 04/27/2018)

Symbol: SLP
Analyst: Howard Halpern
Taglich Rating: Buy
Price Target: $20.50
Time Horizon: 12 Months
Rating Established: July 17, 2015
Price When Established: $6.68
Most Recent Report: April 27, 2018
Price When Issued: $17.65


What's New

Simulations Plus Reports 3Q18 Results

On JuLY 10, 2018, Simulations Plus reported results for 3Q18, ended May 31, 2018.

SLP reported revenues of $8.6 million and net income of $2.4 million or $0.13 per share. In 3Q17 the company reported revenues of $6.7 million and net income of $2.1 million or $0.12 per share.

Taglich Brothers’ estimated revenues of $7.9 million and net income of $2.2 million or $0.12 per share.


Simulations Plus Names Shawn O'Conner as CEO

On June 26, 2018, Simulations Plus announced that Shawn M. O’Connor became its CEO effective June 26, 2018.

Mr. O’Connor brings more than thirty years of executive experience from multiple industries with companies ranging from start-ups to publicly traded companies. He most recently served as president, CEO, and a director of Entelos, a provider of quantitative systems pharmacology software and services to the pharmaceutical drug development market. His prior experience includes served as chairman, president, and CEO of Pharsight Corporation, a developer and marketer of software products and services that help pharmaceutical and biotechnology companies improve their decision-making in drug development and commercialization.

Walt Woltosz, the company’s founder will remain engaged with the company to assist Mr. O’Connor during the transition and thereafter as an outside director.


Company Description

Simulations Plus, Inc., based in Lancaster, California, is a developer of drug discovery and development software, which is licensed to and used in drug research by major pharmaceutical and biotechnology companies worldwide.


Company Reports

Updated Research Report (April 27, 2018)
Updated Research Report (January 18, 2018)
Updated Research Report (December 1, 2017)
Updated Research Report (Dated July 19, 2017)
Updated Research Report (Dated April 24, 2017)
Updated Research Report (Dated January 13, 2017)
Updated Research Report (Dated December 2, 2016)
Updated Research Report (Dated August 3, 2016)
Updated Research Report (Dated April 22, 2016)
Updated Research Report (Dated January 27, 2016)
Updated Research Report (Dated December 9, 2015)
Updated Research Report (Dated July 17, 2015)
Updated Research Report (Dated April 23, 2015)
Updated Research Report (Dated January 29, 2015)
Updated Research Report (Dated December 16, 2014)
Research Note Released (Dated September 8, 2014)
Updated Research Report (Dated July 23, 2014)
Updated Research Report (Dated April 28, 2014)
Updated Research Report (Dated January 17, 2014)
Updated Research Report (Dated November 26, 2013)
Updated Research Report (Dated July 18, 2013)
Updated Research Report (Dated April 18, 2013)
Updated Research Report (Dated January 18, 2013)
Updated Research Report (Dated December 10, 2012)
Updated Research Report (Dated July 16, 2012)
Updated Research Report (Dated April 18, 2012)
Updated Research Report (Dated January 23, 2012)
Updated Research Report (Dated December 15, 2011)
Updated Research Report (Dated July 22, 2011)
Updated Research Report (Dated May 10, 2011)
Updated Research Report (Dated January 21, 2011)
Updated Research Report (Dated December 22, 2010)
Updated Research Report (Dated July 27, 2010)
Updated Research Report (Dated April 27, 2010)
Updated Research Report (Dated February 4, 2010)
Updated Research Report (Dated December 18, 2009)
Updated Research Report (Dated July 28, 2009)
Updated Research Note (Dated June 15, 2009)
Updated Research Update (Dated April 30, 2009)
Updated Earnings Note (Dated April 15, 2009)
Updated Research Report (Dated February 4, 2009)
Updated Earnings Note (Dated January 15, 2009)
Updated Research Report (Dated December 15, 2008)
Updated Research Report (Dated December 15, 2008)
Updated Research Report (Dated August 18, 2008)
Updated Earnings Note (Dated July 15, 2008)
Updated Research Report (Dated May 12, 2008)
Updated Earnings Note (Dated April 15, 2008)
Updated Research Report (Dated February 1, 2008)
Updated Earnings Note (Dated January 14, 2008)
Updated Research Report (Dated December 14, 2007)
Updated Earnings Note (Dated November 26, 2007)
Updated Research Report (Dated July 16, 2007)
Updated Research Report (Dated April 26, 2007)
Updated Research Note (Dated March 26, 2007)
Updated Research Report (Dated January 31, 2007)
Updated Research Report (Dated December 26, 2006)
Updated Research Report (Dated August 7, 2006)
Updated Research Report (Dated May 8, 2006)
Updated Research Report (Dated February 16, 2006)
Updated Research Report (Dated December 22, 2005)
Updated Research Report (Dated July 26, 2005)
Updated Research Report (Dated May 10, 2005)
Updated Research Report (Dated February 17, 2005)
Updated Research Report (Dated December 20, 2004)
Initial Research Report (Dated July 26, 2004)

Disclaimer

Please view our current disclosure and disclaimer on our most recent research report.